Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study
V. Sigurdsson et al., Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study, J CUT PATH, 27(9), 2000, pp. 429-435
Background: Erythroderma, or generalized erythema of the skin, may result f
rom different causes. At present it is unclear whether the underlying patho
-mechanisms that lead to erythroderma are identical or different depending
on the original disease. The aim of this study was to investigate the derma
l cytokine profile in different types of erythroderma and mycosis fungoides
.
Methods: Snap-frozen skin biopsy specimens from 33 patients with erythroder
ma were studied. Thirteen had idiopathic erythroderma, 7 erythrodermic atop
ic dermatitis, 5 Sezary syndrome and 8 had erythroderma from miscellaneous
causes. We also studied 6 patients with mycosis fungoides (5 plaques and 1
tumor) and 5 healthy non-atopic volunteers. The biopsies were immunohistoch
emically stained for interleukin 4 (IL-4) and interferon gamma (IFN-gamma).
All positive cells for IL-4 and IFN-gamma in the dermis were counted and t
he number of positive cells was calculated per mm(2) IL-4/IFN-gamma ratio w
as calculated for each biopsy.
Results: The patients with idiopathic erythroderma, atopic dermatitis and m
iscellaneous erythroderma, all showed more IFN-gamma-positive cells than IL
-4-positive cells in the dermis. The median IL-4-/IFN-gamma ratio for these
three groups was 0.6, 0.9 and 0.45, respectively. These differences were n
ot statistically significant. All patients with Sezary syndrome however, sh
owed more IL-4-positive cells than IFN-gamma-positive cells. The median IL-
4/IFN-gamma ratio was 1.8, which is significantly higher than in the other
groups (p<0.05). In mycosis fungoides roughly the same number of cells expr
essed IL-4 and IFN-gamma. The median IL-4/IFN-gamma ratio was 1.0, which is
significantly lower than in Sezary syndrome (p<0.05).
Conclusions: The dermal infiltrate in patients with Sezary syndrome mainly
shows a T-helper 2 (Th2) cytokine profile, this in contrast to T-helper 1 (
Th1) cytokine profile in benign reactive erythroderma. This indicates that
although a relative uniform clinical picture of erythroderma is obvious, a
different patho-mechanisms may be underlying.